Labelling Compliance for Medical Devices: Wanted Global Harmonisation!

Pharma IQ

Peter Schroeer, Director Europe, Quality Systems & Regulatory Affairs at Johnson & Johnson, speaks to Andrea Charles from Pharma IQ, about the current  compliance challenges the medical device market faces and what impact the reuse warning statement requirement per directive 2007/47/EC has had on global labeling strategies. He also shares his top 3 tips for defining and implementing a global labeling strategy and his insights on what future global...
To continue reading this story get free access